| Is the pendulum of antimicrobial drug resistance swinging back after COVID-19? F Serapide, A Quirino, V Scaglione, HL Morrone, F Longhini, A Bruni, ... Microorganisms 10 (5), 957, 2022 | 24 | 2022 |
| Metabolic-dysfunction-associated fatty liver disease and gut microbiota: From fatty liver to dysmetabolic syndrome L Abenavoli, GGM Scarlata, E Scarpellini, L Boccuto, R Spagnuolo, ... Medicina 59 (3), 594, 2023 | 17 | 2023 |
| Omic insights into various ceftazidime-avibactam-resistant Klebsiella pneumoniae isolates from two southern Italian regions D Bongiorno, DA Bivona, C Cicino, EM Trecarichi, A Russo, N Marascio, ... Frontiers in Cellular and Infection Microbiology 12, 1010979, 2023 | 10 | 2023 |
| Ultrasound prevalence and clinical features of nonalcoholic fatty liver disease in patients with inflammatory bowel diseases: A real-life cross-sectional study L Abenavoli, R Spagnuolo, GGM Scarlata, E Scarpellini, L Boccuto, ... Medicina 59 (11), 1935, 2023 | 7 | 2023 |
| Gut microbiota and liver transplantation: immune mechanisms behind the rejection L Abenavoli, GGM Scarlata, MR Paravati, L Boccuto, F Luzza, ... Biomedicines 11 (7), 1792, 2023 | 4 | 2023 |
| HCV antibody prevalence and genotype evolution in a teaching hospital, Calabria Region, southern Italy over a decade (2008-2018) N Marascio, M Mazzitelli, GGM Scarlata, A Giancotti, GS Barreca, ... The Open Microbiology Journal 14 (1), 2020 | 4 | 2020 |
| Orthopedic device-related infections due to emerging pathogens diagnosed by a combination of microbiological approaches: case series and literature review A Quirino, N Marascio, GGM Scarlata, C Cicino, G Pavia, M Pantanella, ... Diagnostics 12 (12), 3224, 2022 | 3 | 2022 |
| Post-Coronavirus Disease 2019 Pandemic Antimicrobial Resistance L Boccabella, EG Palma, L Abenavoli, GGM Scarlata, M Boni, G Ianiro, ... Antibiotics 13 (3), 233, 2024 | 2 | 2024 |
| Therapeutic success in primary biliary cholangitis and gut microbiota: a safe highway? L Abenavoli, GG Scarlata, E Scarpellini, AC Procopio, FR Ponziani, ... Minerva Gastroenterology, 2024 | 2 | 2024 |
| Prevalence of Colonization with Multidrug-Resistant Bacteria: Results of a 5-Year Active Surveillance in Patients Attending a Teaching Hospital A Quirino, C Cicino, GGM Scarlata, N Marascio, G Di Gennaro, G Matera, ... Antibiotics 12 (10), 1525, 2023 | 2 | 2023 |
| Gut Microbiota and Critically Ill Patients: Immunity and Its Modulation via Probiotics and Immunonutrition L Abenavoli, E Scarpellini, MR Paravati, GGM Scarlata, L Boccuto, ... Nutrients 15 (16), 3569, 2023 | 2 | 2023 |
| Perspective on the Role of Gut Microbiome in the Treatment of Hepatocellular Carcinoma with Immune Checkpoint Inhibitors L Abenavoli, M Montori, G Svegliati Baroni, ME Argenziano, F Giorgi, ... Medicina 59 (8), 1427, 2023 | 2 | 2023 |
| The Role of Gut Microbiota in the Clinical Outcome of Septic Patients: State of the Art and Future Perspectives N Marascio, GGM Scarlata, F Romeo, C Cicino, EM Trecarichi, A Quirino, ... International Journal of Molecular Sciences 24 (11), 9307, 2023 | 2 | 2023 |
| In vitro Activity of Cefiderocol Against Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates: A Single Center Experience A Quirino, C Cicino, V Scaglione, N Marascio, F Serapide, GGM Scarlata, ... Mediterranean Journal of Hematology and Infectious Diseases 15 (1), 2023 | 2 | 2023 |
| Liver Damage and Impaired Coagulation in COVID-19 Patients: A Case Series L Abenavoli, I Aquila, MA Sacco, GGM Scarlata, AC Procopio, L Boccuto, ... Diseases 11 (4), 141, 2023 | 1 | 2023 |
| Changing epidemiology of hepatitis C in Italy: a population-based survey in a historically high endemic area. E Spada, C Marcantonio, MF Vescio, N Marascio, U Villano, G Pisani, ... Minerva Medica, 2021 | 1 | 2021 |
| Onion Polyphenols as Multi-Target-Directed Ligands in MASLD: A Preliminary Molecular Docking Study MR Paravati, AC Procopio, M Milanović, GGM Scarlata, N Milošević, ... Nutrients 16 (8), 1226, 2024 | | 2024 |
| Change in Diagnosis of Helicobacter pylori Infection in the Treatment-Failure Era R Spagnuolo, GGM Scarlata, MR Paravati, L Abenavoli, F Luzza Antibiotics 13 (4), 357, 2024 | | 2024 |
| OC. 16.10: FATTY LIVER IN IBD PATIENTS: FINDINGS FROM AN OBSERVATIONAL RETROSPECTIVE CROSS-SECTIONAL STUDY LA Montebianco, R Spagnuolo, GGM Scarlata, E Suraci, R Marasco, ... Digestive and Liver Disease 56, S207, 2024 | | 2024 |
| The Role of Cytokines in the Pathogenesis and Treatment of Alcoholic Liver Disease GGM Scarlata, C Colaci, M Scarcella, M Dallio, A Federico, L Boccuto, ... Diseases 12 (4), 69, 2024 | | 2024 |
Ludovico AbenavoliMagna Graecia University of Catanzaro, ItalyVerified email at unicz.it
